Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02944994 · ClinicalTrials.gov registry record · NA

Effectiveness of a Unified Transdiagnostic Treatment in Routine Care

A NA study of Depression and Anxiety, sponsored by Boston University.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT02944994: Completed NA study of Depression and Anxiety, sponsored by Boston University.

NCT02944994 is a NA study of Depression and Anxiety that has completed, run by Boston University. The registered enrollment target is 71 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02944994, a NA study of Depression and Anxiety, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine effectiveness and implementation for the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in trauma exposed veterans.

Primary Outcome

These interviews will occur at one time point and will be analyzed with Qualitative Comparative Analyses guided by the Consolidated Framework for Implementation Research. Qualitative analyses are often descriptive in nature and a summary of common themes are reported to speak to factors impacting implementation of the intervention in this population. NVivo software will be used to aggregate the qualitative interviews from all participants and highlight the common themes across CFIR interviews

Interventions

  • OTHER Routine Care
  • OTHER Unified protocol

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System - Boston

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2014-12
Est. Completion 2019-02-12
Phase NA
Boston University

185 total trials

What the finished NCT02944994 record still lists

NCT02944994 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.

NCT02944994 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02944994 about?

NCT02944994 is a clinical study titled "Effectiveness of a Unified Transdiagnostic Treatment in Routine Care". The purpose of this study is to examine effectiveness and implementation for the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in trauma exposed veterans.

What is the current status of trial NCT02944994?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2014-12. Estimated completion is 2019-02-12.

What conditions does trial NCT02944994 study?

This clinical trial studies the following conditions: Depression, Anxiety, Traumatic Stress Disorders.

What interventions are being tested in trial NCT02944994?

The interventions under investigation include: Routine Care (OTHER), Unified protocol (OTHER).

Who is sponsoring clinical trial NCT02944994?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02944994 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02944994's enrollment target sits among peer trials

71 404th of 679 higher than 274 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02944994, the US trial registry maintained by the National Library of Medicine. NCT02944994 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.